J. Behr (Munich, Germany), A. Bast (Maastricht, Netherlands)
Effects of a neutrophil elastase inhibitor against mediators of acute exacerbation of pulmonary fibrosis: a new therapeutic strategy
M. Ebina, H. Ohta, E. Sato, S. Hisata, N. Hirota, T. Miyasho, T. Nukiwa (Sendai/Miyagi, Ebetsu/Hokkaido, Japan)
|  |
Reduction of in-hospital mortality in patients with acute exacerbation of interstitial pneumonia recognized after introduction of non-invasive ventilation
K. Tomii, K. Ishihara, N. Katakami, T. Nishimura, M. Hayashi, Y. Takeshima, R. Kaji (Kobe, Hyogo, Japan)
|   |
Acute respiratory failure in idiopathic pulmonary fibrosis: is there a role for mechanical ventilation?
C. Mollica, G. Paone, V. Conti, G. Schmid, N. Perrone, P. Mattia, R. Orsetti, A. Sebastiani, L. Cecchini (Rome, Italy)
| |
Elevated alveolar antioxidant levels in chronic fibrosing interstitial lung diseases
P. Markart, T. Luboeinski, R. Schmidt, M. Wygrecka, P. Mahavadi, M. Korfei, K. Mayer, W. Seeger, A. Guenther, C. Ruppert (Giessen, Germany)
| |
Dietary crude fish oil attenuate bleomycine induced lung fibrosis in rats
S. Ben Khamsa, M. Ben Brahim, O. Ben Abdelkader, F. Tritar, S. Maalej, N. Kouirda (Tunis, Ariana, Tunisia)
| |
Associations between emphysema and pulmonary fibrosis are suggestive of a smoking pathogenesis common to both disorders
K. Antoniou, D. Hansell, M. Rubens, K. Marten, R. Tennant, T. Hansel, S. Desai, N. Siafakas, R. duBois, A. Wells (Heraklion, Greece; London, United Kingdom; Wuerzburg, Germany)
| |
5-lipoxygenase inhibitor therapy in IPF
K. Flaherty, F. Martinez, G. Toews, D. Dahlgren, M. Peters-Golden (Ann Arbor, MI, United States Of America)
| |
Effects of compound salvia miltiorrhiza injection on lung oxidative injury by using rat precision-cut lung slices
Y. Zhao, X. Wang, Y. Zheng (Shanghai, China)
| |